To amend the Federal Food, Drug, and Cosmetic Act to expand certain authorities with respect to the recall of controlled substances to apply with respect to all drugs, and for other purposes

Progress

Timeline

• Mar 18Referred to the House Committee on Energy and Commerce.

Summary

**What it does:** This bill would expand the Food and Drug Administration's (FDA) authority to recall dangerous drugs. Currently, the FDA has strong recall powers specifically for controlled substances (like opioids and other regulated drugs). This bill would extend those same powers to cover all prescription and over-the-counter medications. **Who it affects:** - Patients who take any medications - Drug manufacturers and distributors - Pharmacies and healthcare providers - The FDA and other regulatory agencies **What would change:** The FDA would gain stronger authority to quickly remove unsafe drugs from the market, regardless of whether they're controlled substances. This could lead to faster recalls when safety problems are discovered, potentially preventing harm to patients. Drug companies would face enhanced oversight and stricter compliance requirements for all their products, not just controlled substances. The bill is currently under review in congressional committee and has not yet been voted on.

How This Affects You